TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive AACR President: Cancer Program ‘Threatened,’ Calls For Strategic Plan, More Extramural Input December 6, 1991